Detalhe da pesquisa
1.
Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents.
Cell
; 186(5): 1013-1025.e24, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827973
2.
N-Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874370
3.
New insights about vaccine effectiveness: Impact of attenuated PRRS-strain vaccination on heterologous strain transmission.
Vaccine
; 38(14): 3050-3061, 2020 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32122719
4.
Micrococcin P1 - A bactericidal thiopeptide active against Mycobacterium tuberculosis.
Tuberculosis (Edinb)
; 100: 95-101, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27553416
5.
Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.
Science
; 348(6239): 1106-12, 2015 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26045430
6.
Milk complement and the opsonophagocytosis and killing of Staphylococcus aureus mastitis isolates by bovine neutrophils.
Microb Pathog
; 34(1): 1-9, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12620379